Industry Insights & News 2018-10-28T20:05:45+00:00

Industry News

News & Statements

The Digital Therapeutics Alliance convenes thought leaders from across the industry – including DTx companies, patients, healthcare providers, payers, and industry partners – to establish foundational best practices and frameworks related to DTx product validation, operations, value, and regulatory oversight.

DTA Participates in the Frontiers Health Summit

Digital Therapeutic Alliance member company leaders Pierre Leurent, CEO, Voluntis, Anand Iyer, Chief Strategy Officer, WellDoc, and Vincent Hennemand, VP of Strategy, Corporate & BD, Akili Interactive, will present at the Frontiers Health Summit on [...]

Load More Posts

Industry Insights

Digital therapeutics form an independent category of evidence-based products within the broader digital health landscape. These products are distinguished from other digital health categories by their primary function of delivering software-generated therapeutic interventions directly to patients to prevent, manage, or treat a medical disorder or disease. DTx products will increasingly influence the way healthcare is delivered and consumed across the world.

Can “Digital Therapeutics” Be as Good as Drugs?

MIT Technology Review (by Christina Farr) -- Entrepreneurs are betting on apps that improve—or just replace—prescription medication. What if an app could replace a pill? That’s the big question behind an emerging trend known [...]

Is Digital Therapeutics the Next Big Thing in mHealth?

mHealth Intelligence (by Eric Wicklund) -- A relatively new mHealth platform known as digital therapeutics is poised to take healthcare by storm. Also commonly known as software-as-a-drug, the industry currently consists of a few dozen startups [...]

When Software Eats Bio

Andreessen Horowitz (byVijay Pande): The other huge area of interest for us is “digital therapeutics”...The way I like to think of it is this: If the first phase of medicine was about small-molecule drugs delivered [...]

Load More Posts

DTx Research & Studies

Digital therapeutics present the market with evidence-based technologies that have the ability to elevate medical best practices, address unmet medical needs, expand healthcare access, and improve clinical and health economic outcomes.

Load More Posts

Stay Up To Date

SIGN UP FOR DTA NEWS & UPDATES

Sign Up Now